- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Adenocarcinoma in South Africa
Total 1392 results
-
City of Hope Medical CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingBreast Ductal Carcinoma In SituUnited States, Canada, Puerto Rico, Korea, Republic of
-
AstraZenecaCompletedBreast CancerUnited States, South Africa, Spain, France, Netherlands, United Kingdom, Greece, Canada
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruiting
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States, South Africa
-
Hoosier Cancer Research NetworkSanofi; Hoffmann-La Roche; Walther Cancer InstituteCompletedMetastatic Breast CancerUnited States
-
University Hospital OstravaUniversity of Ostrava; Silesian Hospital in Opava; Masaryk Memorial Cancer Institute and other collaboratorsCompleted
-
Trans Tasman Radiation Oncology Group3MCompleted
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
Olema Pharmaceuticals, Inc.Active, not recruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States, Australia
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Hoosier Cancer Research NetworkUnited States Department of Defense; Indiana University School of Medicine; Walther...TerminatedBreast CancerUnited States, Peru
-
Case Comprehensive Cancer CenterTerminatedBreast Cancer | Colorectal Cancer | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Breast Cancer - ER+, HER2 - | Breast Cancer - ER+, HER2-, PIK3CA Gene MutationUnited States, United Kingdom
-
Eli Lilly and CompanyCompletedBreast NeoplasmsUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Netherlands, Canada
-
Konica Minolta Medical Imaging, USACompletedBreast CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnEsophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction AdenocarcinomaUnited States
-
Case Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
SCRI Development Innovations, LLCSanofiCompleted
-
Novartis PharmaceuticalsTerminated
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Korea, Republic of, Spain
-
Hoosier Cancer Research NetworkNovartis Pharmaceuticals; Walther Cancer InstituteTerminated
-
Hoosier Cancer Research NetworkPurdue University; Indiana University School of MedicineCompletedBreast CancerUnited States
-
Establishment LabsRecruiting
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Completed
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Virginia Commonwealth UniversityCompletedLymphoma | Breast Cancer | Hodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than TwoUnited States
-
Cancer Trials IrelandTerminated
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Mexico, Brazil, Germany, Peru, Poland, Spain, Taiwan, South Africa, Czechia, Italy, Australia, Hungary
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
AbbVieRecruitingHepatocellular Carcinoma | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Biliary Tract Cancers | Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer | Head and Neck Squamous-Cell CarcinomaUnited States, Israel, Japan, Puerto Rico
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | Joint PainUnited States
-
Barwon HealthAstraZenecaCompletedBreast CancerAustralia
-
Genentech, Inc.CompletedColorectal CancerUnited States
-
Australasian Gastro-Intestinal Trials GroupUniversity of SydneyActive, not recruitingPancreatic Ductal Adenocarcinoma | Metastatic Pancreatic CancerAustralia, New Zealand
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Gilead SciencesRecruitingBreast Cancer | Triple Negative Breast Cancer | PD-L1 NegativeUnited States
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Gilead SciencesTerminatedPreviously Untreated Pancreatic Ductal Adenocarcinoma | Relapsed/Refractory Pancreatic Ductal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States